These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 35090515)

  • 1. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12.
    Chen Z; Zhong X; Xia M; Liu C; Tang W; Liu G; Yi Y; Guo Y; Jiang Q; Zu X; Zhong J
    Cell Death Dis; 2024 Oct; 15(10):733. PubMed ID: 39379360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
    Ji FH; Fu XH; Li GQ; He Q; Qiu XG
    Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
    Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
    Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2.
    Ji X; Lv C; Huang J; Dong W; Sun W; Zhang H
    Cancer Sci; 2023 Jun; 114(6):2318-2334. PubMed ID: 36851875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTO facilitates cancer metastasis by modifying the m
    Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
    Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.
    Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K
    Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
    Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
    Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m
    Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
    Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
    Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
    Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion.
    Xie D; Yang K; Xu Y; Li Y; Liu C; Dong Y; Chi J; Yin X
    J Diabetes Complications; 2024 Aug; 38(8):108801. PubMed ID: 38935979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 17. Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells.
    Li XD; Wang MJ; Zheng JL; Wu YH; Wang X; Jiang XB
    Cancer Sci; 2021 Nov; 112(11):4543-4552. PubMed ID: 34390075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 restrains papillary thyroid cancer progression via m
    He J; Zhou M; Yin J; Wan J; Chu J; Jia J; Sheng J; Wang C; Yin H; He F
    Mol Ther; 2021 May; 29(5):1821-1837. PubMed ID: 33484966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Hou R; Wang Y; Cao S; Sun X; Jiang L
    Lab Invest; 2024 Jun; 104(6):102059. PubMed ID: 38615731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.